<DOC>
	<DOCNO>NCT01806363</DOCNO>
	<brief_summary>Clinical trial evaluate pharmacokinetic interaction safety telmisartan chlorthalidone .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Safety Study Telmisartan Chlorthalidone</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<criteria>1 . Healthy male subject 2 . Age ( yr ) 20 50 3 . Signed write informed consent 1 . Known hypersensitivity investigator product , thiazide , sulphonamide drug additive . 2 . History siginificant Sickness , Cardiovascular , Respiratory , Renal , Endocrine , Neurological , Psychic , Cancer , Gasstrointestinal , Hematologic . 3 . History drug and/or alcohol abuse 4 . Over 10 tobacco day 5 . Other condition opinion investigator preclude enrollment study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Safety</keyword>
	<keyword>Male</keyword>
</DOC>